Trial record 1 of 1 for:
VCTX210
An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05210530 |
|
Recruitment Status :
Completed
First Posted : January 27, 2022
Last Update Posted : June 26, 2023
|
Sponsor:
CRISPR Therapeutics AG
Collaborator:
ViaCyte
Information provided by (Responsible Party):
CRISPR Therapeutics ( CRISPR Therapeutics AG )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | January 19, 2023 |
| Actual Study Completion Date : | January 19, 2023 |